Related Experiment Video
Updated: Aug 11, 2026

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
Effect of opioid active therapeutics on the ascending reflex pathway in the rat ileum
H D Allescher1, M Storr, C Piller
1Department of Internal Medicine II, Technical University of Munich, Ismaningerstr. 22, 81675 Munich, Germany. hans.allescher@lrz.tu-muenchen.de
Abstract:
For a long time therapeutic agents that interact with opioid receptors have been used in antidiarrheal therapy. The action of the opioid active substances on motility and transit have already been characterized; however, their effects on myenteric reflexes and their possible luminal action have not yet been investigated. Loperamide, fedotozine and beta-casomorphin-4, as well as the casomorphin-analogue beta-CM-4027, are, or have been, suggested as therapeutic agents and were studied in the isolated rat ileum for their effect on the ascending reflex pathway. beta-CM-4027 > fedotozine > loperamide > beta-casomorphin-4 caused a concentration-dependent inhibition of the ascending contractile reflex response with an IC(50)of 1.4x10(-7)M, 1.5x10(-6)M, 4.1x10(-6)M and 4.5x10(-6)M respectively. At the same time as the oral contractile reflex response was inhibited, all four opioid agonists (CM-4027 > beta-casomorphin-4 > fedotozine > loperamide) increased the latency of the reflex response. Both effects were blocked by naloxone, indicating the involvement of opioid receptors. These results demonstrate that opioid-active drugs and substances modify the peristaltic reflex by reducing the efficacy of the reflex response and modulating the timing of the reflex pathway. In a second series of experiments, luminal application of opioid-active drugs was compared with serosal application. beta-casomorphine-4 caused a concentration-dependent inhibition of the oral reflex response with an IC(50)of 3x10(-3)M which was 750 times higher than after serosal application. In contrast, a stable and highly selective kappa opioid agonist (U-50,488), which caused potent inhibition upon serosal application (IC(50): 2.3x10(-7)M), showed no inhibitory effect after luminal application up to a concentration of 10(-2)M. Thus casomorphins could have a local effect on the gut wall with no need for systemic absorption. This might be used for a possible therapeutic application.
Insights
Opioid receptor agonists like loperamide inhibit antidiarrheal reflexes by affecting myenteric reflexes. Casomorphins may offer localized gut therapy without systemic absorption, suggesting new therapeutic applications.
Area of Science:
- Pharmacology
- Gastroenterology
- Neuroscience
Background:
- Opioid receptor agonists are established antidiarrheal agents.
- Their effects on gut motility are known, but impact on myenteric reflexes and luminal action is unclear.
Purpose of the Study:
- Investigate the effects of opioid-active substances on myenteric reflexes in the isolated rat ileum.
- Compare luminal versus serosal application of these agents.
Main Methods:
- Studied ascending contractile reflex pathway in isolated rat ileum.
- Utilized opioid agonists (loperamide, fedotozine, beta-casomorphin-4, beta-CM-4027) and naloxone.
- Compared luminal and serosal drug application.
Main Results:
- Opioid agonists inhibited reflex response efficacy and increased reflex latency, effects blocked by naloxone.
- beta-CM-4027 showed the most potent inhibition (IC50: 1.4x10(-7)M).
- Beta-casomorphin-4 demonstrated a localized effect, requiring 750x higher concentration luminally than serosally.
Conclusions:
- Opioid drugs modulate peristaltic reflexes by altering efficacy and timing via opioid receptors.
- Casomorphins may exert local effects on the gut wall, suggesting potential for targeted antidiarrheal therapies.
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

